MarginsXMarginsX
Home › Markets › Health Care › PPCB

Propanc Biopharma Inc. (PPCB)

PPCB trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.89
-2.62% on the day
Market cap
$2.0M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerPPCB on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryAustralia
IPO yearNot reported by the screener
SEC CIK0001517681
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Foreign filer: no machine-readable annual figure in SEC data.

Warning signs

Cash runway
1.8 months
$832K cash at June 30, 2026
Share count, 1 year
+1860.9%
2025-11-13 to 2026-11-12 · +2254.7% over 3 years
Going-concern doubt
Yes
10-Q filed November 13, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"It is management's opinion that these conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of at least twelve months from the issue date of this Quarterly Report."
10-Q 2026-11-13
Cash and burn$832K cash; operating cash flow -$1.4M a quarter.Report 2026-06-30
Shares outstanding1,048,247 (2026-11-12); 13,364,244 a year earlier; 22,258,941 three years earlier. 1y figure adjusted for splits (1-for-250 overall); 3y figure adjusted for splits (1-for-500 overall).Cover page 2026-11-12
Reverse splits, 3 years3; latest 1-for-10 on 2026-10-26Source 2026-10-26
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 months2 (8-K item 3.01)8-K 2026-10-29
AuditorSalberg & Company, P.A., Boca Raton, Florida, United StatesPCAOB Form AP 2026-09-30
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q4 2026
2026-06-30
Not filed-$4.6M-$1.6M$832K$201KNeeds four quarters10-K 2026-09-25
Q3 2026
2026-03-31
Not filed-$6.4M-$1.1M$444K$55KNeeds four quarters10-Q 2026-05-14
Q2 2026
2025-12-31
Not filed-$3.1M-$999K$561K$55KNeeds four quarters10-Q 2026-05-14
Q1 2026
2025-09-30
Not filed-$4.8M-$1.9M$603K$107KNeeds four quarters10-Q 2026-05-14
Q4 2025
2025-06-30
Not filed-$4.1M-$92K$12K$538KNeeds four quarters10-K 2026-09-25
Q3 2025
2025-03-31
Not filed-$54.1M-$96K$51K$439KNeeds four quarters10-Q 2026-05-14
Q2 2025
2024-12-31
Not filed-$430K$19K$15K$410KNeeds four quarters10-Q 2026-05-14
Q1 2025
2024-09-30
Not filed-$354K-$236K$9K$382KNeeds four quarters10-Q 2026-05-14

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-12026-10-05
Latest annual report10-K2026-09-25
Latest quarterly / interim10-Q2026-11-13
Latest current report8-K2026-10-29
Latest proxyPRE 14A2026-03-19

Source: SEC EDGAR submissions feed, 439 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+9.7%
1 month-52.9%
3 months-84.1%
Year to date-98.6%
1 year-99.0%
From 52-week high-99.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ONCOOnconetix Inc.$2.91-9.35%$1.9M
XRTXXORTX Therapeutics Inc. Common Shares$1.04-5.45%$1.9M
CMNDClearmind Medicine Inc. Common Shares$4.18-7.67%$2.1M
SBFMSunshine Biopharma Inc.$2.60-3.70%$2.1M
DCOYDecoy Therapeutics Inc.$0.9010-7.61%$2.1M
HCWBHCW Biologics Inc.$0.8000+3.48%$1.8M
JUNSJupiter Neurosciences Inc.$1.70-8.11%$2.2M
SXTP60 Degrees Pharmaceuticals Inc.$0.4938-4.65%$1.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier